Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
X842 capsule in duodenal ulcer (phase III)
CTR20254718Phase 3Active
- Sponsor
- Sino-Nordic Pharmaceutical
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of linaprazan glurate in duodenal ulcer, sponsored by Sino-Nordic Pharmaceutical. Started Dec 2025; status: active.
02
Drugs
linaprazan glurate
03
Conditions
duodenal ulcer
Beyond the preview
Go deeper on CTR20254718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254718.